Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Genome-Wide Sequence Analysis of Kaposi Sarcoma-Associated Herpesvirus Shows Diversification Driven by Recombination.

Domain:

healthcare

Record type:

dataset
Creator:
SalPalWatson, Simon J.Lab
Editor:
ApoUni
Publisher:
Oxf
Host:avatar
BACKGROUND: Kaposi sarcoma-associated herpesvirus (KSHV) establishes lifelong infection in the human host and has been associated with a variety of malignancies. KSHV displays striking geographic variation in prevalence, which is highest in sub-Saharan Africa. The current KSHV genome sequences available are all tumor cell line-derived or primary tumor-associated viruses, which have provided valuable insights into KSHV genetic diversity. METHODS: Here, we sequenced 45 KSHV genomes from a Ugandan population cohort in which KSHV is endemic; these are the only genome sequences obtained from nondiseased individuals and of KSHV DNA isolated from saliva. RESULTS: Population structure analysis, along with the 25 published genome sequences from other parts of the world, showed whole-genome variation, separating sequences and variation within the central genome contributing to clustering of genomes by geography. We reveal new evidence for the presence of intragenic recombination and multiple recombination events contributing to the divergence of genomes into at least 5 distinct types. DISCUSSION: This study shows that large-scale genome-wide sequencing from clinical and epidemiological samples is necessary to capture the full extent of genetic diversity of KSHV, including recombination, and provides evidence to suggest a revision of KSHV genotype nomenclature.

Visit

doi.orgwww.repository.cam.ac.uk

Tags

AdolescentAdultAgedAged, 80 and overCohort StudiesDNA, ViralFemaleGenome-Wide Association StudyGenomicsHerpesvirus 8, Human+8

Licenses

Creative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcodeopen.accesshttp://purl.org/coar/access_right/c_abf2

Similar

Risk factors for kaposi sarcoma-associated herpesvirus (KSHV) and kaposi sarcoma (KS) mortality in sub-Saharan Africa, TheAdmitted AIDS-associated Kaposi sarcoma patientsKaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicinGenome-Wide Fine-Scale Recombination Rate Variation in <em>Drosophila melanogaster</em>A prospective study of clinical outcomes of HIV-associated and HIV-negative Kaposi sarcoma in Uganda

Risk factors for kaposi sarcoma-associated herpesvirus (KSHV) and kaposi sarcoma (KS) mortality in sub-Saharan Africa, The

The largest worldwide burden of Kaposi sarcoma (KS), 85% of all cases, is found in sub-Saharan Afric

Admitted AIDS-associated Kaposi sarcoma patients

Abstract Kaposi sarcoma (KS) is an AIDS-defining angioproliferative malignancy associa

Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.

BACKGROUND: Endemic Kaposi's sarcoma (KS) is a clinically and epidemiologically distinct human immun

Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin

Abstract Background Kaposi’s sarcoma (KS) is a common HIV-associated malignancy frequently associ

Genome-Wide Fine-Scale Recombination Rate Variation in <em>Drosophila melanogaster</em>

Estimating fine-scale recombination maps of Drosophila from population genomic data

A prospective study of clinical outcomes of HIV-associated and HIV-negative Kaposi sarcoma in Uganda

Objective: Improved understanding of the effect of HIV infection on Kaposi sarcoma (KS